Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFKB1 | P19838 | 2/20 | 0.52 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.52 |
| ▸ | RELA | Q04206 | 2/20 | 0.52 |
| ▸ | NR1H2 | P55055 | 6/20 | 0.49 |
| ▸ | NR1H3 | Q13133 | 6/20 | 0.49 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.49 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.49 |
| ▸ | POLB | P06746 | 6/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.33 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.33 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | BCHE | P06276 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acerogenin A SCHEMBL10048511 | 1.00 | NFKB1 (0.52) | NFKB1NFKB2RELANR1H2NR1H3 | |
| Acerogenin B SCHEMBL13698043 | 1.00 | NFKB1 (0.52) | NFKB1NFKB2RELANR1H2NR1H3 | |
| Acerogenin A SCHEMBL329008 | 1.00 | NFKB1 (0.52) | NFKB1NFKB2RELANR1H2NR1H3 | |
| SCHEMBL18126510 | 0.85 | NR1H2 (0.48) | NFKB1NFKB2RELANR1H2NR1H3 | |
| SCHEMBL10048501 | 0.80 | NR1H2 (0.49) | NFKB1NFKB2RELANR1H2NR1H3 | |
| SCHEMBL10048502 | 0.80 | NR1H2 (0.44) | NFKB1NFKB2RELANR1H2NR1H3 | |
| Acerogenin K SCHEMBL13698051 | 0.77 | NFKB1 (0.47) | NFKB1NFKB2RELAPOLBLMNA | |
| Acerogenin C SCHEMBL4112475 | 0.77 | NFKB1 (0.56) | NFKB1NFKB2RELANR1H2NR1H3 | |
| SCHEMBL329311 | 0.76 | NFKB1 (0.44) | NFKB1NFKB2RELA | |
| SCHEMBL368382 | 0.76 | NFKB1 (0.44) | NFKB1NFKB2RELA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4267103-A1 | PLANT EXTRACTS FOR IMPROVING SKIN BARRIER FUNCTION | Oriflame Cosmetics AG (CH) | 2023-11-01 | — | — | EP | claimed |
| WO-2022135827-A1 | PLANT EXTRACTS FOR IMPROVING SKIN BARRIER FUNCTION | ORIFLAME COSMETICS AG (CH) | 2022-06-30 | — | — | WO | claimed |
| EP-1569628-B1 | NOVEL USE OF LYCOPENE FOR THE TREATMENT OF DISEASES ASSOCIATED WITH ANDROGEN SIGNALLING | DSM IP ASSETS BV (NL) | 2009-07-22 | — | — | EP | claimed |
| US-20060069151-A1 | Novel use of lycopene | DSM IP ASSETS B.V. (NL) | 2006-03-30 | — | — | US | claimed |
| EP-1569628-A1 | NOVEL USE OF LYCOPENE | DSM IP Assets B.V. (NL) | 2005-09-07 | — | — | EP | claimed |
| WO-2004052351-A1 | NOVEL USE OF LYCOPENE | DSM IP ASSETS B.V. (CH) | 2004-06-24 | — | — | WO | claimed |
| JP-10139601-A | — | — | None | — | — | JP | disclosed |
| EP-4267103-A1 | PLANT EXTRACTS FOR IMPROVING SKIN BARRIER FUNCTION | Oriflame Cosmetics AG (CH) | 2023-11-01 | — | — | EP | disclosed |
| US-11661584-B2 | Method for maintaining undifferentiation potency of mesenchymal stem cell employing shaking suspension culture | TOHOKU UNIVERSITY (JP) | 2023-05-30 | — | — | US | disclosed |
| WO-2022135827-A1 | PLANT EXTRACTS FOR IMPROVING SKIN BARRIER FUNCTION | ORIFLAME COSMETICS AG (CH) | 2022-06-30 | — | — | WO | disclosed |
| US-20210366578-A1 | EMBRYONIC DNA REGISTRY | PRICE INDIA TRENIEK (US) | 2021-11-25 | — | — | US | disclosed |
| US-20210139855-A1 | METHOD FOR MAINTAINING UNDIFFERENTIATION POTENCY OF MESENCHYMAL STEM CELL EMPLOYING SHAKING SUSPENSION CULTURE | TOHOKU UNIVERSITY (JP) | 2021-05-13 | — | — | US | disclosed |
| WO-2021072473-A1 | ANTIMICROBIALS AS FEED PRESERVATIVES | IRP Health Pty Ltd (AU) | 2021-04-22 | — | — | WO | disclosed |
| EP-1569628-B1 | NOVEL USE OF LYCOPENE FOR THE TREATMENT OF DISEASES ASSOCIATED WITH ANDROGEN SIGNALLING | DSM IP ASSETS BV (NL) | 2009-07-22 | — | — | EP | disclosed |
| EP-2050442-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTION AND/OR TREATMENT OF BONE DISEASE, FUNCTIONAL FOOD OR HEALTH FOOD COMPRISING THE COMPOSITION, AND PHARMACEUTICAL PREPARATION COMPRISING THE COMPOSITION AS ACTIVE INGREDIENT | Akihisa, Toshihiro (JP) | 2009-04-22 | — | — | EP | disclosed |
| US-20060069151-A1 | Novel use of lycopene | DSM IP ASSETS B.V. (NL) | 2006-03-30 | — | — | US | disclosed |
| CN-1720030-A | The new purposes of lycopene | DSM IP ASSETS BV (NL) | 2006-01-11 | — | — | CN | disclosed |
| EP-1569628-A1 | NOVEL USE OF LYCOPENE | DSM IP Assets B.V. (NL) | 2005-09-07 | — | — | EP | disclosed |
| WO-2004052351-A1 | NOVEL USE OF LYCOPENE | DSM IP ASSETS B.V. (CH) | 2004-06-24 | — | — | WO | disclosed |
| JP-H10139601-A | ANTIMICROBIAL AND ANTIMICROBIAL COSMETIC MATERIAL CONTAINING THE SAME | NOEVIR CO LTD | 1998-05-26 | — | — | JP | disclosed |